Oxybutynin Chloride Tablet
Product Images NDC 64980-734

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 64980-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5mg-1000s-container-label (5mg 1000s Container Label)

Label for Oxybutynin Chloride Tablets, USP 5 mg oral tablets, containing 1000 tablets. The label shows the product name, strength, quantity, and that it is Rx only. Manufactured for Rising Pharma Holdings, Inc. The label includes dosage information and storage instructions, with the NDC 64980-679-10 and manufacturer details (Piramal Pharma Limited, India).*

FDA Label Image

5mg-100s-container-label (5mg 100s Container Label)

Oxybutynin Chloride Tablets, USP 5 mg oral tablets by Rising Pharma Holdings, Inc. The label shows a bottle size of 100 tablets. The label includes storage instructions, dosage and administration notes, and manufacturer information including Manufacturing by Piramal Pharma Limited in India and labeler Rising Pharma Holdings, Inc., East Brunswick, NJ. The label has the NDC 64980-679-01 and a barcode.*

FDA Label Image

5mg-500s-container-label (5mg 500s Container Label)

Label for Oxybutynin Chloride Tablets, USP 5 mg oral tablets, supplied in a 500 tablet count. The label includes dosage instructions, storage conditions, and manufacturing information by Rising Pharma Holdings, Inc. It displays the National Drug Code (NDC) 64980-679-50 and a barcode. The label warns to keep the medication out of reach of children and indicates Rx only.*

FDA Label Image

Figure 1 (Oxybutynin Figure1)

A pharmacokinetic line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours (Time in hours) after administration of Oxybutynin 5 mg taken three times daily (TID). The graph illustrates concentration peaks and declines at multiple time points with associated error bars.*

FDA Label Image

Figure 2 (Oxybutynin Figure2)

A line graph showing mean plasma concentration of R-0 oxybutynin (ng/mL) over time (hours). The x-axis represents time from 0 to 12 hours, and the y-axis concentration ranges from 0 to 10 ng/mL. Data points with error bars indicate concentration peaks around 1 hour and gradual decline thereafter.*

FDA Label Image

Structure (Oxybutynin Structure)

Chemical structure diagram of Oxybutynin Chloride, showing its molecular arrangement including aromatic rings and functional groups as depicted in the product data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.